Brief report · 30 Apr 2025
Conference abstractPublished 22 Jul 2022
Epigenetics in Melodys plastic syndromes.
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Epigenetics links developmental biology, genetics and environment. Dysregulation of epigenetic events can lead to evolution of several diseases including cancer. Various types of epigenetic therapies can potentially treat many diseases such as myelodysplastic syndromes, solid tumors, autoimmune diseases and neurological disorders. The two main classes of epigenetic therapies are inhibitors of the enzymes DNA methyltransferase and histone deacetylase. Despite the progress achieved after introduction of epigenetic therapies, particularly the hypomethylating drugs azacitidine and decitabine, in the management of patients with myelodysplastic syndromes further efforts are needed to improve the outcome of these patients. This is an updated review on epigenetics, epigenetic targets and existing as well as evolving epigenetic therapeutics in myelodysplastic syndromes. However, the hypomethylating agents azacitidine and decitabine as well as histone deacetylase inhibitors will be thoroughly discussed.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Genetics and Medicine.
Commentary · 30 Apr 2025
Plant Molecular Genetics: Crop Improvement and Sustainability
Perspective · 30 Apr 2025
Multi-omics Integration: Bridging Genomics, Proteomics and Metabolomics
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Genetics and Medicine
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Al-Anazi WK”

